PRESS RELEASE published on 04/22/2026 at 22:00, 27 days 7 hours ago Inventiva renforce son équipe de direction à l’approche des résultats de Phase 3 du lanifibranor Inventiva renforce son équipe de direction avec trois nouveaux membres pour préparer les résultats de Phase 3 du lanifibranor. Des experts en finance, juridique et ressources humaines renforcent l'organisation Recrutement Phase 3 Équipe De Direction Inventiva Lanifibranor
PRESS RELEASE published on 04/22/2026 at 22:00, 27 days 7 hours ago Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor Inventiva strengthens leadership team with new key hires for lanifibranor Phase 3 data readout, bolstering expertise in finance, legal, and HR to drive growth and commercialization Growth Leadership Team Phase 3 Inventiva Lanifibranor
BRIEF published on 04/08/2026 at 22:05, 1 month 11 days ago Inventiva Submits 2025 Financial Reports to AMF and SEC Inventiva 2025 Financial Reports MASH Treatments Biopharmaceutical Developments AMF And SEC Filings
BRIEF published on 04/08/2026 at 22:05, 1 month 11 days ago Inventiva Dépose son Document d'Enregistrement Universel et son Rapport Annuel 2025 Biopharmaceutique Rapport Annuel Document D'enregistrement Inventiva MASH
BRIEF published on 04/08/2026 at 22:05, 1 month 11 days ago Inventiva files its Universal Registration Document and its 2025 Annual Report Annual Report Biopharmaceutical Registration Document Inventiva MASH
BRIEF published on 04/08/2026 at 22:05, 1 month 11 days ago Inventiva soumet ses rapports financiers 2025 à l'AMF et à la SEC Inventive Rapports Financiers 2025 Traitements MASH Développements Biopharmaceutiques Documents Déposés Auprès De L'AMF Et De La SEC
PRESS RELEASE published on 04/08/2026 at 22:00, 1 month 11 days ago Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2025 et de son Rapport Annuel 2025 (« Form 20-F ») Inventiva annonce le dépôt de son Document d'Enregistrement Universel 2025 et de son Rapport Annuel 2025 ("Form 20-F") pour traitement MASH Biopharmaceutique Inventiva MASH Rapport Annuel 2025 Document D'enregistrement Universel 2025
PRESS RELEASE published on 04/08/2026 at 22:00, 1 month 11 days ago Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F Inventiva files 2025 Universal Registration Document and Annual Report on Form 20-F with AMF and SEC, focusing on MASH therapies Biopharmaceutical 2025 Filing Inventiva MASH
BRIEF published on 04/02/2026 at 15:55, 1 month 17 days ago J.P. Morgan Chase & Co. franchit les seuils de participation chez INVENTIVA Droits De Vote Franchissement De Seuil Inventiva J.P. Morgan Equity Swap
BRIEF published on 04/02/2026 at 15:55, 1 month 17 days ago JP Morgan Chase & Co. crosses the thresholds for participation in INVENTIVA Voting Rights Threshold Crossing JP Morgan Inventiva Equity Swap
Published on 05/20/2026 at 03:21, 2 hours 29 minutes ago Challenger Assays Extend New Open Pittable Mineralisation
Published on 05/20/2026 at 00:00, 5 hours 50 minutes ago Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Published on 05/19/2026 at 19:45, 10 hours 5 minutes ago Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative
Published on 05/19/2026 at 16:47, 13 hours 3 minutes ago Lithium South Re-Schedules Plan of Arrangement Closing as a Result of Cease Trade Order
Published on 05/19/2026 at 15:15, 14 hours 35 minutes ago Loop Industries Secures Gujarat Government Alignment Supporting First Commercial Deployment and Multi-Phase India Expansion
Published on 05/19/2026 at 21:24, 8 hours 26 minutes ago EQS-Adhoc: ams OSRAM announces the successful pricing of EUR 1 billion 7.250% Senior Notes due 2032, supporting the path to positive Free Cash Flow from 2027 onwards
Published on 05/19/2026 at 19:50, 10 hours ago EQS-Adhoc: fox e-mobility AG: 3 convertible bonds issued
Published on 05/19/2026 at 19:40, 10 hours 10 minutes ago PRC-Saltillo Named to Forbes Accessibility 200 List
Published on 05/19/2026 at 19:05, 10 hours 45 minutes ago Casper Ruud Returns to Stockholm as Bybit EU Expands Across the Nordics
Published on 05/19/2026 at 18:56, 10 hours 54 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/19/2026 at 18:34, 11 hours 15 minutes ago Availability of preparatory documents for the annual general meeting to be held on June 9, 2026
Published on 05/19/2026 at 18:34, 11 hours 15 minutes ago Mise à disposition des documents préparatoires à l’assemblée générale annuelle mixte des actionnaires du 9 juin 2026
Published on 05/19/2026 at 18:30, 11 hours 20 minutes ago TERACT- Communiqué InVivo Group - Retrait obligatoire
